CDKN2A/P16 expression in mycosis fungoides

被引：0
|
作者：
Fargnoli, MC
Chimenti, S
Stanta, G
Bonin, S
Amantea, A
Felli, A
Peris, K
机构：
[1] UNIV AQUILA,DEPT DERMATOL,I-67100 LAQUILA,ITALY
[2] UNIV TRIESTE,DEPT PATHOL,I-34127 TRIESTE,ITALY
[3] INT CTR GENET ENGN & BIOTECHNOL PADRICIANO,TRIESTE,ITALY
[4] IRCCS,IST SAN GALLICANO,ROME,ITALY
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 1997年 / 109卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：487 / 487
页数：1
相关论文
共 50 条
  • [1] Reduced expression of CDKN2a/p16INK4a in mycosis fungoides
    Peris, K
    Stanta, G
    Fargnoli, MC
    Bonin, S
    Felli, A
    Amantea, A
    Chimenti, S
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 1999, 291 (04) : 207 - 211
  • [2] Reduced expression of CDKN2a/p16INK4a in mycosis fungoides
    K. Peris
    Giorgio Stanta
    Maria Concetta Fargnoli
    Serena Bonin
    Andrea Felli
    Ada Amantea
    Sergio Chimenti
    Archives of Dermatological Research, 1999, 291 : 207 - 211
  • [3] CDKN2A/p16 in ependymomas
    Simona Bortolotto
    Loredana Chiadò-Piat
    Paola Cavalla
    Ivana Bosone
    Alessandro Mauro
    Davide Schiffer
    Journal of Neuro-Oncology, 2001, 54 : 9 - 13
  • [4] CDKN2A/p16 in ependymomas
    Bortolotto, S
    Chiadò-Piat, L
    Cavalla, P
    Bosone, I
    Mauro, A
    Schiffer, D
    JOURNAL OF NEURO-ONCOLOGY, 2001, 54 (01) : 9 - 13
  • [5] CDKN2A/p16 evaluation in cytology specimens
    Xing, Juan
    Griffith, Christopher C.
    CANCER CYTOPATHOLOGY, 2023, 131 (11) : 672 - 676
  • [6] The CDKN2A (p16) Gene and Human Cancer
    William D. Foulkes
    Tamar Y. Flanders
    Pamela M. Pollock
    Nicholas K. Hayward
    Molecular Medicine, 1997, 3 : 5 - 20
  • [7] The CDKN2A (p16) gene and human cancer
    Foulkes, WD
    Flanders, TY
    Pollock, PM
    Hayward, NK
    MOLECULAR MEDICINE, 1997, 3 (01) : 5 - 20
  • [8] CDKN2A/p16 inactivation in the prognosis of oligodendrogliomas
    Bortolotto, S
    Chiadò-Piat, L
    Cavalla, P
    Bosone, I
    Chiò, A
    Mauro, A
    Schiffer, D
    INTERNATIONAL JOURNAL OF CANCER, 2000, 88 (04) : 554 - 557
  • [9] CDKN2A/p16 is inactivated by the combination of inversion and translocation
    Norris, Alexis L.
    Kamiyama, Hirohiko
    Hruban, Ralph H.
    Eshleman, James R.
    CANCER RESEARCH, 2015, 75
  • [10] Implications of P16/CDKN2A deletion in pleural mesotheliomas
    Ladanyi, M
    LUNG CANCER, 2005, 49 : S95 - S98
12345